A Randomized Placebo-controlled Phase II Study of Intercalated Administration of Pemetrexed/Cisplatin With Iressa (Gefitinib) or Placebo as First-line Treatment of Stage IIIB/IV Lung Adenocarcinoma in Never-smokers
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Pemetrexed
- Indications Lung cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results (n=76) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 09 Sep 2015 Interim results (n=76) presented at the 16th World Conference on Lung Cancer
- 19 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.